Xtant Medical Holdings, Inc. (XTNT): Price and Financial Metrics

Xtant Medical Holdings, Inc. (XTNT): $0.53

0.01 (-2.22%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

XTNT Price/Volume Stats

Current price $0.53 52-week high $1.45
Prev. close $0.55 52-week low $0.51
Day low $0.53 Volume 50,700
Day high $0.57 Avg. volume 100,392
50-day MA $0.61 Dividend yield N/A
200-day MA $0.80 Market Cap 69.60M

XTNT Stock Price Chart Interactive Chart >


Xtant Medical Holdings, Inc. (XTNT) Company Bio


Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and devices in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as could be used in conjunction with a hardware plate system. The company is based in Montana.


XTNT Latest News Stream


Event/Time News Detail
Loading, please wait...

XTNT Latest Social Stream


Loading social stream, please wait...

View Full XTNT Social Stream

XTNT Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Continue Researching XTNT

Want to see what other sources are saying about Xtant Medical Holdings Inc's financials and stock price? Try the links below:

Xtant Medical Holdings Inc (XTNT) Stock Price | Nasdaq
Xtant Medical Holdings Inc (XTNT) Stock Quote, History and News - Yahoo Finance
Xtant Medical Holdings Inc (XTNT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!